EZH2 Silencing with RNA Interference Induces G2/M Arrest in Human Lung Cancer Cells In Vitro

被引:13
作者
Xia, Hui [1 ]
Zhang, Wen [1 ]
Li, Yingjie [1 ]
Guo, Nannan [1 ]
Yu, Changhai [1 ]
机构
[1] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Thorac Cardio Surg, Beijing 100048, Peoples R China
关键词
CYCLE ARREST; P53; CHECKPOINT; EXPRESSION; INHIBITION; APOPTOSIS; RECEPTOR; PATHWAY; DOWNSTREAM; ABROGATION;
D O I
10.1155/2014/348728
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nonsmall-cell lung cancer has a high mortality rate and poor prognosis. In the present study, we silenced EZH2 and explored the consequent cell cycle changes. The expression of cell-cycle-related proteins, including p53, p21, Cdc2, and cyclin B1, was detected with western blotting, and the cell cycle distribution was determined with flow cytometry. Inhibition of EZH2 expression changed the cell cycle distribution, in particular inducing G(2)/M arrest. Expression of Cdc2 and cyclin B1 was significantly decreased in A549 and HTB-56 cells after EZH2-siRNA treatment. In addition, p53 expression was increased by 21% and 18%, and p21 expression was increased by 31% and 23%, in A549 and HTB-56 cells, respectively, in the presence of EZH2-siRNA. This study clearly demonstrates that modulation of EZH2 expression with siRNA affects the cell cycle and the expression levels of p53 and p21, thereby changing cyclin B1 and Cdc2 expression and inducing G(2)/M arrest. These results may explain the observed antitumor activity of EZH2 silencing. Such explorations of the molecular mechanism of EZH2 will help us develop novel approaches to the diagnosis, treatment, and prevention of nonsmall-cell lung cancer.
引用
收藏
页数:8
相关论文
共 36 条
[11]   Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21waf1/cip1-independent pathway in human colorectal cancer cells [J].
Kalimutho, Murugan ;
Minutolo, Antonella ;
Grelli, Sandro ;
Federici, Giorgio ;
Bernardini, Sergio .
ACTA PHARMACOLOGICA SINICA, 2011, 32 (11) :1387-1396
[12]   Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells [J].
Kim, Eunhee ;
Kim, Misuk ;
Woo, Dong-Hun ;
Shin, Yongjae ;
Shin, Jihye ;
Chang, Nakho ;
Oh, Young Taek ;
Kim, Hong ;
Rheey, Jingeun ;
Nakano, Ichiro ;
Lee, Cheolju ;
Joo, Kyeung Min ;
Rich, Jeremy N. ;
Nam, Do-Hyun ;
Lee, Jeongwu .
CANCER CELL, 2013, 23 (06) :839-852
[13]   Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells [J].
Kreis, N. N. ;
Sanhaji, M. ;
Kraemer, A. ;
Sommer, K. ;
Roedel, F. ;
Strebhardt, K. ;
Yuan, J. .
ONCOGENE, 2010, 29 (41) :5591-5603
[14]   Human Folliculin Delays Cell Cycle Progression through Late S and G2/M-Phases: Effect of Phosphorylation and Tumor Associated Mutations [J].
Laviolette, Laura A. ;
Wilson, Jonas ;
Koller, Julia ;
Neil, Christopher ;
Hulick, Peter ;
Rejtar, Tomas ;
Karger, Barry ;
Teh, Bin Tean ;
Iliopoulos, Othon .
PLOS ONE, 2013, 8 (07)
[15]   Abrogation of the G(2) Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents [J].
Leijen, Suzanne ;
Beijnen, Jos H. ;
Schellens, Jan H. M. .
CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03) :186-191
[16]   The p53-p21 WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function [J].
Lo, Pang-Kuo ;
Lee, Ji Shin ;
Sukumar, Saraswati .
CELLULAR SIGNALLING, 2012, 24 (01) :316-324
[17]   Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16INK4A, p27KIP1, p21WAF1, Ki-67 expression patterns in gastric cancer [J].
Mattioli, Eliseo ;
Vogiatzi, Paraskevi ;
Sun, Ang ;
Abbadessa, Giovanni ;
Angeloni, Giulia ;
Ugo, Domenico D' ;
Trani, Daniela ;
Gaughan, John P. ;
Vecchio, Fabio Maria ;
Cevenini, Gabriele ;
Persiani, Roberto ;
Giordano, Antonio ;
Claudio, Pier Paolo .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 210 (01) :183-191
[18]   EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations [J].
McCabe, Michael T. ;
Ott, Heidi M. ;
Ganji, Gopinath ;
Korenchuk, Susan ;
Thompson, Christine ;
Van Aller, Glenn S. ;
Liu, Yan ;
Graves, Alan P. ;
Della Pietra, Anthony, III ;
Diaz, Elsie ;
LaFrance, Louis V. ;
Mellinger, Mark ;
Duquenne, Celine ;
Tian, Xinrong ;
Kruger, Ryan G. ;
McHugh, Charles F. ;
Brandt, Martin ;
Miller, William H. ;
Dhanak, Dashyant ;
Verma, Sharad K. ;
Tummino, Peter J. ;
Creasy, Caretha L. .
NATURE, 2012, 492 (7427) :108-+
[19]   New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy [J].
Mirzayans, Razmik ;
Andrais, Bonnie ;
Scott, April ;
Murray, David .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
[20]   Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells [J].
Munagala, Radha ;
Kausar, Hina ;
Munjal, Charu ;
Gupta, Ramesh C. .
CARCINOGENESIS, 2011, 32 (11) :1697-1705